DRÄGERWERK AG & CO. KGAA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 50.8 EUR | 0.00% |
|
+0.40% | -1.93% |
| Apr. 16 | DRÄGERWERK AG & CO KGAA : Silver lining beyond the soft Q124 headline figures |  |
| Apr. 16 | DRAEGERWERK : Hauck & Aufhauser remains its Buy rating | ZD |
| Sales 2024 * | 3.46B 3.71B | Sales 2025 * | 3.61B 3.87B | Capitalization | 883M 946M |
|---|---|---|---|---|---|
| Net income 2024 * | 86M 92.1M | Net income 2025 * | 106M 114M | EV / Sales 2024 * | 0.29 x |
| Net Debt 2024 * | 125M 133M | Net Debt 2025 * | 177M 190M | EV / Sales 2025 * | 0.29 x |
| P/E ratio 2024 * |
11
x | P/E ratio 2025 * |
8.98
x | Employees | 15,750 |
| Yield 2024 * |
3.43% | Yield 2025 * |
2.2% | Free-Float | 61.21% |
More Fundamentals
* Assessed data
More news
Latest transcript on Drägerwerk AG & Co. KGaA
More recommendations
More press releases
| 1 week | +0.40% | ||
| Current month | -0.20% | ||
| 1 month | +2.83% | ||
| 3 months | +0.20% | ||
| 6 months | +5.72% | ||
| Current year | -1.93% |
1 week
48.65
52.00
1 month
48.6553.40
Current year
45.5053.80
1 year
41.7556.20
3 years
38.2082.70
5 years
38.20108.50
10 years
38.20123.70
| Managers | Title | Age | Since |
|---|---|---|---|
Stefan Dräger
CEO | Chief Executive Officer | 61 | 91-12-31 |
| Director of Finance/CFO | 56 | 07-12-31 | |
Anton Schrofner
CTO | Chief Tech/Sci/R&D Officer | 60 | 09-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Maria Dietz
BRD | Director/Board Member | 62 | 18-05-03 |
Stefan H. Lauer
CHM | Chairman | 69 | 12-12-31 |
| Director/Board Member | 64 | 07-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.93% | 125 M€ | -.--% | ||
| 0.33% | 17 M€ | -.--% | - | |
| 0.00% | 773 M€ | -.--% | - | |
| 0.00% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 50.8 | 0.00% | 6,292 |
| 24-04-22 | 50.8 | +2.52% | 10,946 |
| 24-04-19 | 49.55 | +1.02% | 5,676 |
| 24-04-18 | 49.05 | -2.68% | 12,978 |
| 24-04-17 | 50.4 | -0.40% | 4,767 |
Delayed Quote Xetra, April 23, 2024 at 11:35 am EDT
More quotes
Draegerwerk AG & Co KGaA is a Germany-based provider of medical and safety technology. The Company operates through two segments: Medical and Safety. The Medical segment develops, produces and markets system solutions, equipment and services for the optimization of processes at the acute point of care, such as emergency care, preoperative care, critical care and prenatal care. The Safety segment develops, produces and markets products, system solutions and services for personal protection, gas detection technology and integrated hazard management for customers from various industries, such as mining, fire departments, police and disaster protection. The Company has production sites in Europe, the Americas, Africa and Asia.
Calendar
2024-04-25
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
50.8
EUR
Average target price
56.25
EUR
Spread / Average Target
+10.73%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -1.93% | 944M | |
| +8.35% | 209B | |
| +9.41% | 175B | |
| +11.75% | 131B | |
| +19.34% | 99.98B | |
| -0.84% | 61.12B | |
| +15.08% | 52.34B | |
| -2.10% | 46.5B | |
| +0.10% | 39.24B | |
| +11.50% | 38.47B |
- Stock Market
- Equities
- DRW3 Stock
